Company Filing History:
Years Active: 2013-2015
Title: Kouki Morizono: Innovator in Targeted Lentiviral Vectors
Introduction
Kouki Morizono is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of biotechnology, particularly in the development of targeted lentiviral vectors. With a total of 2 patents, Morizono's work is paving the way for advancements in gene therapy and diagnostic applications.
Latest Patents
Morizono's latest patents focus on "Targeting pseudotyped retroviral vectors." This invention provides targeted lentiviral vectors that are pseudotyped with mutated Sindbis envelopes. Mutations in the Sindbis E2 protein are utilized to alter viral titer, specificity, specificity index, tropism, and susceptibility to host immune response. Typically, one or more of the E1, E2, or E3 proteins can be mutated at one or more amino acid positions. The pseudotyped, targeted lentiviral vectors of this invention are designed to transduce heterologous genes into a cell and can be applied for in vivo and ex vivo therapeutic applications, as well as for diagnostic and research tool applications.
Career Highlights
Morizono is affiliated with the University of California, where he continues to advance his research and innovations. His work is instrumental in the ongoing development of gene therapy techniques that have the potential to transform medical treatments.
Collaborations
Some of Morizono's notable coworkers include Irvin S. Y. Chen and Irvin Sy Chen. Their collaborative efforts contribute to the innovative research environment at the University of California.
Conclusion
Kouki Morizono is a key figure in the field of biotechnology, with a focus on targeted lentiviral vectors. His inventions are set to make a significant impact on therapeutic and diagnostic applications in the future.